RobertHGrossMD

PubMed

• 1 citations
  Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis.
  Britney Barrera, Haley Simpson, Eric Engebretson, Stefan Sillau, Brooke Valdez, José Parra-González, Ryan C Winger, Lou Anne Epperson, Ashley Banks, Kathryn Pierce, Me...> ;Annals of Clinical and Translational Neurology. 2023 Apr 1
• 1 citations
  Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis.
  Rebecca I Spain, Andrea Hildebrand, Carin S Waslo, William D Rooney, Joshua Emmons, Daniel L Schwartz, Mark S Freedman, M Mateo Paz Soldan, Pavle Repovic, Andrew J Sol...> ;Frontiers in Neurology. 2023 Jan 1
• 5 citations
  Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapse
  Rebecca Farber, Robert Gross, Elina Zakin, Michelle Fabian> ;Multiple Sclerosis. 2017 Jun 1
• Prediction of HIV Virologic Failure Among Adolescents Using the Pediatric Symptom Checklist.
  Lowenthal ED, Marukutira T, Tshume O, Chapman J, Anabwani GM, Gross R> ;AIDS Behav. 2015-11-01
• Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitors.
  Brier MJ, Chambless D, Gross R, Su HI, DeMichele A, Mao JJ> ;Eur. J. Cancer. 2015-09-01
• Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA.
  Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, Bushman FD, Li H> ;Bioinformatics. 2015-08-01
• 4 citations
  Alemtuzumab in multiple sclerosis: an update
  Robert Gross, Stephen Krieger> ;Neurodegenerative Disease Management. 2015 Jun 24
• 9 citations
  Tentorial dural arteriovenous fistula presenting as myelopathy: Case series and review of literature.
  Robert Gross, Rushna Ali, Max Kole, Curtis Dorbeistein, Mahesh V Jayaraman, Muhib Khan> ;World Journal of Clinical Cases. 2014 Dec 16
• 30 citations
  Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments
  Robert Gross, Brian C. Healy, Sabine Cepok, Tanuja Chitnis, Samia J. Khoury, B. Hemmer, Howard L. Weiner, David A. Hafler, Philip L. De Jager> ;Journal of Neuroimmunology. 2011 Apr 1
• Validity and comparison of two measures of days supply in Medicaid claims data.
  Gross R, Bilker WB, Strom BL, Hennessy S> ;Pharmacoepidemiol Drug Saf. 2008-10-01
• How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?
  Gross R, Bilker WB, Wang H, Chapman J> ;HIV Clin Trials. 2008-01-01
• Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector.
  Bisson GP, Frank I, Gross R, Lo Re V, Strom JB, Wang X, Mogorosi M, Gaolathe T, Ndwapi N, Friedman H, Strom BL, Dickinson D> ;AIDS. 2006-06-12
• 1 citations
  Cognitive Impairments Preceding and Outlasting Autoimmune Limbic Encephalitis.
  Robert Gross, Jennifer D. Davis, Julie L. Roth, Henry W. Querfurth> ;Case Reports in Neurological Medicine. 2016 Jan 10
• Join now to see all

Books/Book Chapters

• Neuroimmunology: Multiple Sclerosis and Related Disorders 
  Chapter: MS: Epidemiology and Genetics 
  Page 71 - 87Robert H Gross and Philip L De JagerEditors: Rizvi S, Coyle P.Humana Press2011